These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9736816

  • 41. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 42. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.
    Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ.
    Am J Kidney Dis; 1999 Nov; 34(5):809-17. PubMed ID: 10561135
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [Abstract] [Full Text] [Related]

  • 49. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H, Yasuda G, Takizawa T, Shionoiri F.
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract] [Full Text] [Related]

  • 52. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [Abstract] [Full Text] [Related]

  • 53. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 54. Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months.
    Gerdts E, Svarstad E, Aanderud S, Myking OL, Lund-Johansen P, Omvik P.
    Am J Hypertens; 1998 Oct; 11(10):1178-87. PubMed ID: 9799034
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM, RENAAL Study Group.
    Arch Intern Med; 2003 Jul 14; 163(13):1555-65. PubMed ID: 12860578
    [Abstract] [Full Text] [Related]

  • 58. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O, Boully C, Caillard L, Labourée F, Cochiello S, Chaussade E.
    Am J Hypertens; 2015 Aug 14; 28(8):1064-71. PubMed ID: 25628416
    [Abstract] [Full Text] [Related]

  • 59. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH.
    Horm Metab Res; 2005 Apr 14; 37 Suppl 1():4-8. PubMed ID: 15918104
    [Abstract] [Full Text] [Related]

  • 60. Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
    Ekholm M, Jekell A, Wallén NH, Gigante B, Kahan T.
    J Cardiovasc Pharmacol; 2018 Apr 14; 71(4):240-247. PubMed ID: 29389738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.